Mitsubishi Research Institute (JP:3636)
:3636
Want to see JP:3636 full AI Analyst Report?
3636 Stock Chart & Stats
¥4860.00
-¥5.00(-0.10%)
At close: 4:00 PM EST
¥4860.00
-¥5.00(-0.10%)
Day’s Range― - ―
52-Week Range¥4,380.00 - ¥5,360.00
Previous CloseN/A
Volume35.50K
Average Volume (3M)24.01K
Market Cap
¥71.32B
Enterprise Value¥56.12B
Total Cash (Recent Filing)¥30.31B
Total Debt (Recent Filing)¥1.04B
Price to Earnings (P/E)7.1
Beta0.83
Next Earnings
Jul 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.28%
Share Statistics
EPS (TTM)405.58
Shares Outstanding16,044,000
10 Day Avg. Volume20,130
30 Day Avg. Volume24,010
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)1.13
Price to Sales (P/S)0.67
P/FCF Ratio29.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)398.05
Revenue Forecast (FY)¥125.11B
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetExtremely low debt-to-equity (0.014) gives durable financial flexibility: supports funding of projects, cushions cyclicality in client budgets, and reduces refinancing risk. This balance sheet strength enables strategic investment without pressuring cash flow over the medium term.
Consistent Revenue Growth And Improving MarginsSustained revenue growth with higher gross margin (24.91%) and a positive net margin (5.26%) reflects efficient cost control and stable pricing in consulting and IT services. These trends support durable earnings generation and margin sustainability across multi-year contracts.
Healthy Operating Cash Flow GenerationConsistently healthy operating cash flow indicates the business converts earnings into cash from client-engagement activity and recurring service operations. Stable OCF-to-net-income supports ongoing operations, working-capital needs, and the ability to fund project delivery without external financing.
Bears Say
Declining Free Cash Flow ConversionA meaningful decline in free cash flow growth and lower FCF-to-net-income reduces capacity for discretionary investment, buybacks, or dividend increases. Over time this can constrain strategic initiatives, limit balance-sheet optimization, and weaken resilience to prolonged demand slowdowns.
Softening Return On Equity (ROE)A declining ROE signals the company is generating less profit per unit of shareholder equity. Persistently weaker ROE may reflect margin pressure or lower asset efficiency, reducing the firm's ability to deliver attractive shareholder returns versus peers over the medium term.
Concentration In Fee-based, Project WorkHeavy reliance on fee-based, project-driven contracts—notably public-sector and large enterprise multi-year programs—creates revenue lumpiness and exposure to client budget cycles. This structural concentration raises medium-term variability in bookings and margin timing.
Mitsubishi Research Institute News
3636 FAQ
What was Mitsubishi Research Institute’s price range in the past 12 months?
Mitsubishi Research Institute lowest stock price was ¥4380.00 and its highest was ¥5360.00 in the past 12 months.
What is Mitsubishi Research Institute’s market cap?
Mitsubishi Research Institute’s market cap is ¥71.32B.
When is Mitsubishi Research Institute’s upcoming earnings report date?
Mitsubishi Research Institute’s upcoming earnings report date is Jul 29, 2026 which is in 39 days.
How were Mitsubishi Research Institute’s earnings last quarter?
Mitsubishi Research Institute released its earnings results on Apr 27, 2026. The company reported ¥370.41 earnings per share for the quarter, beating the consensus estimate of N/A by ¥370.41.
Is Mitsubishi Research Institute overvalued?
According to Wall Street analysts Mitsubishi Research Institute’s price is currently Overvalued.
Does Mitsubishi Research Institute pay dividends?
Mitsubishi Research Institute pays a Semiannually dividend of ¥84 which represents an annual dividend yield of 3.28%. See more information on Mitsubishi Research Institute dividends here
What is Mitsubishi Research Institute’s EPS estimate?
Mitsubishi Research Institute’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mitsubishi Research Institute have?
Mitsubishi Research Institute has 16,044,000 shares outstanding.
What happened to Mitsubishi Research Institute’s price movement after its last earnings report?
Mitsubishi Research Institute reported an EPS of ¥370.41 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.419%.
Which hedge fund is a major shareholder of Mitsubishi Research Institute?
Currently, no hedge funds are holding shares in JP:3636
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mitsubishi Research Institute
Mitsubishi Research Institute, Inc. (MRI) is a Japanese firm that delivers a wide array of strategic advisory, information technology, and research services. It caters to a diverse client base within Japan, encompassing governmental entities, financial organizations, and private corporations. The company's extensive solutions span areas such as management consultation, digital and financial innovation, environmental and energy initiatives, healthcare and wellness, regional development, future infrastructure deployment, scientific and safety research, nuclear safety, and broad economic, social, and R&D initiatives. Furthermore, MRI handles specialized project engagements and public sector procurement. In a key collaboration, it partners with ForePaaS SAS to implement cloud-native data-intensive solutions across Japan. Established in 1970, Mitsubishi Research Institute, Inc. is headquartered in Tokyo.
Technical Analysis
Options Prices
Currently, No data available
---